Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cerebrain
- Development stage
- Phase 4
- Lead developer
- Farmaceutici Damor
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cerebrain is a nutraceutical compound formulated as an oral vial containing 1200 mg of choline bitartrate. Developed by the Italian company Farmaceutici DAMOR, it is primarily indicated for the management of cognitive impairment and frailty, particularly in elderly populations or those with hypertension-related cognitive decline. Choline bitartrate serves as a dietary source of choline, a critical precursor for the biosynthesis of acetylcholine, a neurotransmitter essential for memory, mood, and cognitive function. By augmenting cholinergic activity, Cerebrain aims to support brain health and mitigate symptoms of mild cognitive impairment (MCI). It has been evaluated in double-blind, randomized, placebo-controlled clinical trials to assess its impact on cognitive frailty and functional status.
- Brand names
- Cerebrain
- Other names
- Choline bitartrate
Beyond the preview
Go deeper on Cerebrain.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cerebrain.